BCBA/NVS (BCBA/NVS)

Buenos Aires Stock Exchange: BCBA/NVS · ARS

ARS 64,750

+225.83 (+0.3%)· Recorded snapshot

Market cap	451.4T
Revenue (ttm)	87.5T
Net income (ttm)	15.3T
EPS (ttm)	ARS 2,022
P/E (trailing)	32.0x
P/E (forward)	16.1x
Dividend	ARS 988 (1.53%)
Volume	182

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 87.5T
Net income (ttm): 15.3T
EPS (ttm): ARS 2,022
P/E (trailing): 32.0x
P/E (forward): 16.1x
Market cap: 451.4T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E16.1

P25 n/aP50 n/aP75 n/a

Trailing P/E32

P25 n/aP50 n/aP75 n/a

ROE24.3

P25 n/aP50 n/aP75 n/a

ROIC19.3

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/NVS indicators

Market & fundamental data

Available fields

246

Groups with data

Currency

USD

Showing 246 of 246 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	Switzerland
Country code	AR
Earnings date	2026-10-27
Employees	75,267
Employees change	-616
Employees growth	-0.81%
Enterprise value	ARS 513T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-09-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARDEUT112521
Last earnings date	2026-10-27
Last refreshed	2026-10-28
Last stock split date	2020-10-22
Last stock split type	Forward
Market cap	ARS 451.4T
Next earnings date	2027-02-03
Price	ARS 64,750.00
Price currency	ARS
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	bcba/NVS
Website	https://www.novartis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	19.87x
Average P/E ratio (3Y)	17.62x
Average P/E ratio (5Y)	17.8x
Earnings yield	3.12%
EV/Earnings	33.54x
EV/EBIT	17x
EV/EBITDA	13.61x
EV/FCF	21.49x
EV/Sales	5.78x
FCF / EV yield	4.65%
FCF yield	5.29%
Forward P/E	16.08x
Graham number	20138.4654
Graham upside	-68.9%
Lynch fair value	ARS 10,969.61
Lynch upside	-83.06%
P/(FCF - SBC) ratio	20.39x
P/(OCF - SBC) ratio	18.29x
P/B ratio	7.88x
P/E ratio	32.03x
P/FCF ratio	18.91x
P/OCF ratio	17.09x
P/S ratio	5.16x
Price/EBITDA ratio	12.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	33.98%
EBITDA margin	41.94%
Effective tax rate	20.8%
FCF margin	27.07%
Gross margin	75.21%
Operating margin	33.98%
Pretax margin	22.04%
Profit margin	17.49%
Profit per employee	ARS 203.2M
Profitable quarters	106
Profitable years	28
Revenue per employee	ARS 1.2B
ROA	10.86%
ROA (5Y)	7.4%
ROCE	23.04%
ROE	24.33%
ROE (5Y)	23.91%
ROIC	19.26%
ROIC (5Y)	17.5%
SBC / revenue	1.98%
Tax / revenue	4.58%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-28.31%
EPS growth (Q)	-68.81%
EPS growth (QoQ)	-63.16%
EPS growth 10Y	6.32%
EPS growth 3Y	12.03%
EPS growth 5Y	3.87%
EPS growth years	1
FCF growth	-20.02%
FCF growth (Q)	-17.79%
FCF growth (QoQ)	-8.09%
FCF growth 3Y	1.3%
FCF growth 5Y	2.63%
Gross profit growth	0.4%
Gross profit growth (Q)	5.89%
Gross profit growth 3Y	8.64%
Gross profit growth 5Y	3.12%
Net income growth	-30.31%
Net income growth (Q)	-69.4%
Net income growth (QoQ)	-63.17%
Net income growth 3Y	8.58%
Net income growth 5Y	0.45%
Net income growth years	1
OCF growth	-17.79%
OCF growth (Q)	-16.25%
OCF growth (QoQ)	-6.44%
OCF growth 10Y	3.71%
OCF growth 3Y	2.64%
OCF growth 5Y	2.66%
Operating income growth	1.26%
Operating income growth (Q)	16.25%
Operating income growth 3Y	19.41%
Operating income growth 5Y	7.48%
Revenue growth	1.76%
Revenue growth (Q)	4.67%
Revenue growth (QoQ)	0.52%
Revenue growth 10Y	1.46%
Revenue growth 3Y	7.75%
Revenue growth 5Y	1.83%
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -2.5T
Depreciation and amortization	ARS 7T
EBIT	ARS 29.7T
EBITDA	ARS 36.7T
EPS	ARS 2,021.52
Financing cash flow	ARS 1.2T
Free cash flow	ARS 23.9T
Free cash flow minus SBC	ARS 22.1T
Gross profit	ARS 65.8T
Income taxes	ARS 4T
Investing cash flow	ARS -28.5T
Net borrowing	ARS 24.9T
Net cash flow	ARS -1T
Net income	ARS 15.3T
Operating cash flow minus SBC	ARS 24.7T
Operating income	ARS 29.7T
Revenue	ARS 87.5T
Stock-based compensation	ARS 1.7T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.56
Book value per share	ARS 30,058.39
Debt / EBITDA	1.98
Debt / equity	1.29
Debt / FCF	3.09
Goodwill	ARS 41.8T
Interest coverage	12.36
Long-term assets	ARS 134.4T
Long-term liabilities	ARS 71.4T
Net cash (debt)	ARS -60.1T
Net cash / market cap	-13.32%
Net debt / EBITDA	1.64
Net debt / equity	1.05
Net debt / FCF	2.52
Piotroski F-Score	5
Property, plant and equipment	ARS 18.9T
Shareholders' equity	ARS 57.3T
Tangible book value	ARS -45.4T
Tangible book value per share	ARS -24,039.93
Total assets	ARS 178.6T
Total cash	ARS 13.5T
Total debt	ARS 73.7T
Total liabilities	ARS 121.4T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.51
Current assets	ARS 44.2T
Current liabilities	ARS 50T
Current ratio	0.88
Inventory turnover	2.27
Net working capital	ARS -4.2T
Quick ratio	0.58
Working capital	ARS -5.8T
Working capital turnover	-23,080.31

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	2.76%
Dividend growth	58.23%
Dividend growth (10Y)	34.36%
Dividend growth (3Y)	28.65%
Dividend growth (5Y)	80.51%
Dividend growth years	3
Dividend payment date	2026-03-16
Dividend payment years	3
Dividend payout frequency	Annual
Dividend per share	ARS 988.41
Dividend yield	1.53%
Ex-dividend date	2026-03-11
Last dividend	ARS 988.41
Payout ratio	90.4%
Shareholder yield	4.29%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 58,284.83
1D price change	0.35%
1M price change	10.12%
1M total return	10.12%
1W price change	6.37%
1W total return	6.37%
1Y price change	26.9%
1Y return CAGR	29.08%
1Y total return	29.05%
20-day SMA	ARS 59,853.75
200-day SMA	ARS 58,066.00
3M price change	4.86%
3M total return	4.86%
3Y price change	215.85%
3Y return CAGR	49.33%
3Y total return	233.1%
50-day SMA	ARS 59,726.00
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 67,200.00
52-week high date	2026-07-03
52-week low	ARS 43,680.00
52-week low date	2025-10-27
5Y price change	1,430.73%
5Y return CAGR	74.87%
5Y total return	1,534.36%
6M price change	19.08%
6M total return	19.08%
All-time high	ARS 67,200.00
All-time high date	2026-07-03
All-time low	ARS 1,961.00
All-time low date	2020-01-27
Average true range (ATR)	ARS 1,247.21
Average volume	512.6
Change from 52-week high	-3.65%
Change from 52-week low	48.24%
Change from all-time high	-3.65%
Change from all-time low	3,201.89%
Change from open	0.04%
Day's gap	0.31%
Dollar volume	ARS 11.8M
High price	ARS 65,025.00
Low price	ARS 64,450.00
Monthly RSI	71.9
Open price	ARS 64,725.00
Position in 52-week range	52.17%
Previous close	ARS 64,525.00
Price vs 150-day SMA	11.09%
Price vs 20-day SMA	8.18%
Price vs 200-day SMA	11.51%
Price vs 50-day SMA	8.41%
Relative volume	0.36
RSI	69.63
Sharpe ratio	0.98
Sharpe ratio (3Y)	1.22
Sharpe ratio (5Y)	1.67
Sortino ratio	1.51
Sortino ratio (3Y)	1.97
Sortino ratio (5Y)	2.77
Volume	182
Weekly RSI	59.64
YTD price change	22%
YTD total return	24.07%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.9B
Shares change (QoQ)	-0.47%
Shares change (YoY)	-2.76%
Shares held by insiders	0.11%
Shares held by institutions	36.29%

Deeper analysis on BCBA/NVS

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/NVS report

Is a complete BCBA/NVS research report available?

No complete published report is available for bcba/NVS (BCBA/NVS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/NVS (BCBA/NVS)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/NVS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/NVS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/NVS

Frequently asked questions